Concepedia

P A Janssen

PA

22

Publications

1.7K

Citations

17

H-Index

1973

Active since

Affiliations

Janssen (Belgium)(Current)

P A Janssen is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1973–1992

22

Publications

22

Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Jan M. Van Nueten, P A Janssen, Johan van Beek et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 524 citations

Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites.

Didier de Chaffoy de Courcelles, J.E. Leysen, Fred De Clerck et al. · Journal of Biological Chemistry · 1985 · 205 citations · Full text

A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

F. C. Colpaert, C. J. E. Niemegeers, P A Janssen · Journal of Pharmacology and Experimental Therapeutics · 1982 · 167 citations

, , +10

Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.

J. Van Wauwe, G. Van Nyen, M C Coene et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 101 citations

Ca2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine.

Petrus J. Pauwels, Harrie P. van Assouw, J.E. Leysen et al. · Molecular Pharmacology · 1989 · 82 citations

Rows per page

1–5 of 22